Maternal Mortality in Developing Countries:  The Role of the Mexico City Policy by Brancazio, Sophia
 
 
MATERNAL MORTALITY IN DEVELOPING COUNTRIES: THE ROLE OF THE 
MEXICO CITY POLICY  
 
By 
 
Sophia Brancazio 
 
 
A Master’s Paper submitted to the faculty of 
the University of North Carolina at Chapel Hill 
in partial fulfillment of the requirements for  
the degree of Master of Public Health in 
the Public Health Leadership Program 
 
 
Chapel Hill 
2018 
 
 
 
 
 
 
 
 
Sue Tolleson-Rinehart, PhD, Advisor and First Reader 
 
 25 June 2018                  
Date  
 
Jessica Morse MD MPH, Second Reader 
 
20 June 2018  
Date  
 
 
© Sophia Brancazio, 2018
i 
 
 
ABSTRACT 
Sophia Brancazio: Maternal Mortality in Developing Countries:  
The Role of the Mexico City Policy 
(Under the direct supervision of Sue Tolleson-Rinehart, PhD) 
 
The Mexico City Policy prohibits United States aid to foreign non-governmental 
organizations from spending any of their funds on abortion services, education, or referral.  The 
United States has repeatedly enacted and repealed this policy along partisan lines, perhaps at 
times without regard for its possible health and economic effects.  I examined the role of the 
Mexico City Policy on the Maternal Mortality Ratio, a marker of maternal health that, in 2000, 
the World Health Organization pledged to reduce.  This study suggests that the Mexico City 
Policy may play a role in affecting the maternal mortality ratio differently across developing 
countries in Asia, Africa, and Eastern Europe.  This study serves as a preliminary analysis for 
exploration of this policy on maternal mortality. 
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INTRODUCTION 
 Family planning services have the ability to improve health outcomes, yet they also clash 
with traditional views on reproductive autonomy (Canning and Schultz 2012; Shiffman and 
Quissell 2012; Cleland, Bernstein, Ezeh et al. 2006).  Global and national policies revolving 
around family planning and access to reproductive health services often come under great 
scrutiny (Shiffman and Quissell 2012).  Likewise, policies limiting family planning and 
reproductive access create turmoil when they are not evidence-based practices or do not promote 
positive health outcomes (Starrs 2017; Pugh, Desai, Ferguson et al. 2017). 
 One policy that has created such controversy is the Mexico City Policy (abbreviated here 
as MCP and also known as the Global Gag Rule).  President Reagan first introduced this policy 
at the 1984 International Conference on Population (second session), in Mexico City (Reagan 
Administration 1984; The Kaiser Family Foundation 2017).  The MCP prohibits non-
governmental organizations (NGOs) in developing countries that receive United States family 
planning or reproductive health aid to use any of their funding (regardless of source) for abortion 
services, education, or referral (Cohen 2000; The Kaiser Family Foundation 2017; Crane and 
Dusenberry 2004).   These organizations are not only restricted in their inability to spend family 
planning resources from the United States on any abortion-related activity, but they are also 
required to confirm that they are not spending non-US aid on abortion-related activity (Kates and 
Moss 2017; The Kaiser Family Foundation 2017).  In 2017, the Trump administration expanded 
the policy: Not only does the MCP apply to U.S. family planning and reproductive health aid, 
but it now also applies to other types of aid such as support for HIV programs and programs 
targeting malaria (Bingenheimer and Skuster 2017; Latham 2017; Starrs 2017; The Kaiser 
Family Foundation 2017).   
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Notably, prior to creation of the MCP, legislation prohibiting the use of United States 
international aid for abortion services was already in place.  For instance, the Helms 
Amendment, passed by Congress in 1973 as an amendment to the 1961 Foreign Assistance Act, 
restricts any United States international funding of abortion services or assistance “to motivate or 
coerce any person to practice abortions” (P.L. 87-195 sec 104A, 13; Blanchfield 2018).  Despite 
existing restrictive policy, presidential administrations continue to enact and repeal the MCP 
along partisan lines within days of taking office.  Every Republican presidential administration 
has implemented this policy since President Reagan first announced it, and every Democratic 
presidential administration has rescinded it (106th Congress; 66 FR 17301; Clinton Presidential 
Materials Project; 74 FR 4903; 82 FR 8495; The Kaiser Family Foundation 2017). When this 
policy is in place, NGOs subsequently must choose between providing comprehensive 
reproductive services, including abortion services or even referral to or education about such 
services, or receiving international aid from the United States.  
This choice comes at a heavy price for countries that are dependent on international aid to 
deliver effective reproductive health care and health care in general.  Because the United States 
is the largest donor of international aid, countries that choose not to comply with the MCP find 
themselves lacking a large amount of funding for health initiatives and family planning resources 
(Cincotta and Crane 2001; Latham 2017; OECD 2016).  Lack of funding can manifest itself in 
the closure of family planning clinics and increased maternal mortality, given that family 
planning can promote adequate birth spacing and prevent unintended pregnancies (Smith, 
Ashford, Gribble, and Clifton 2009; Mishra 2001).  Cases such as Nepal, where maternal 
mortality increased during times of policy enactment, and Kenya, where numerous clinics 
currently fear closure for lack of adequate funds, exemplify these poorer health outcomes (Ingber 
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2018; Mayhew 2002).  Although the goal of the MCP was to reduce the number of abortions 
performed worldwide, some evidence has suggested that it has done just the opposite (Crane and 
Dusenberry 2004; Bendavid, Avila, and Miller 2011; Latham 2017).  Further, opponents of this 
policy argue that it infringes on human rights by withholding accurate medical information from 
patients in developing countries that rely on such aid (Cincotta and Crane 2001; Cohen 2000).  
Nonetheless, the United States continues to enact this policy based on political ideology without 
apparently weighing what many public health experts believe are the likelihood of its larger 
implications for women’s health across the world. 
The goal of my study was to examine some of the larger health implications of the MCP.  
While there is some research on how the policy affects contraception access and abortion rates in 
developing countries, there is very little research in the area of maternal mortality as it may be 
associated with the MCP.  Given the World Health Organization’s (WHO) commitment to 
improving maternal mortality, I chose to examine whether the MCP is associated with maternal 
mortality (Buse and Hawkes 2015; Starrs 2006; WHO, UNICEF, UNFPA 2015).  Specifically, I 
chose to examine the MCP’s role in the world’s ability to reduce the maternal mortality ratio 
(MMR, or the number of maternal deaths per 100,000 live births), which continues to be a key 
indicator for tracking international maternal outcomes (WHO, UNICEF, UNFPA 2015).  I 
triangulated data from the WHO, United Nations, and several other databases in attempt to 
answer the question: Does MCP enactment play a role in either reducing or increasing MMR? 
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BACKGROUND: THE MATERNAL MORTALITY RATIO 
Improving maternal health care has been a longstanding goal of the WHO.  Maternal 
health care first entered the WHO spotlight at the Safe Motherhood Conference in 1987 when 
researchers highlighted high maternal death rates (Rosenfield and Maine 1985; Starrs 2006).  
The WHO made a global commitment to improve maternal mortality in 2000 when they pledged 
to reduce the maternal mortality ratio (MMR, or the number of maternal deaths per 100,000 live 
births) by three-quarters (United Nations 2000; WHO, UNICEF, UNFPA 2015).  They further 
demonstrated such commitment to maternal health by aiming to reduce MMR to 70 per 100,000 
live births by the year 2030 (from a global MMR of 216 in 2015 [United Nations 2015b; WHO, 
UNICEF, UNFPA 2015]).   Through the declaration of these goals, the WHO established a 
system to accurately measure maternal mortality ratios in order to evaluate the world’s progress 
at achieving these goals.   
The Maternal Mortality Estimation Inter-Agency Group (MMEIG) works to develop 
“comparable MMR estimates” and comprises the WHO, United Nations Children’s Fund 
(UNICEF), the United Nations Population Fund (UNFPA), the World Bank Group, and the UN 
Population Division (UNPD) of the Department of Economic Social Affairs in collaboration with 
the University of Massachusetts Amherst, the National University of Singapore, and the 
University of California at Berkeley (WHO, UNICEF, UNFPA 2015, 1).  The MMEIG uses 
country specific data and country consultations on the “proportion of deaths among women of 
reproductive age that are due to maternal causes” to calculate the MMR (WHO, UNICEF, 
UNFPA 2015, 4).   
It is important to note, however, that for countries that may not have enough data, the 
MMEIG uses a model to estimate MMR.  The model takes into account a country’s GDP, 
  
 
 
5 
spontaneous abortion rates, the percentage of women receiving antenatal care, proportion of 
institutionalized births, and life expectancy, particularly for the twelve countries that have no 
data available for analysis (WHO, UNICEF, UNFPA 2015).  Similarly, the MMEIG notes the 
systematic error associated with calculating the incidence of maternal mortality because there are 
always deaths that will not be reported.  These estimates cause the projected MMR to possibly be 
less than the actual rate.  The MMEIG also considers specialized studies that investigate 
maternal mortalities and population-based surveys (such as the Demographic and Health 
Surveys, or DHS) in their estimates.  Finally, the group uses a validated Bayesian Model 
approach to complete their measures.  Certainly, this calculation is subject to considerable 
systematic bias despite being the best available measurement on maternal mortality.  The 
majority of this measurement bias comes from the fact that these estimates might not even reflect 
true data points but rather be based on the accuracy of the group’s model.  Thus, although these 
measurements provide useful information, especially for considering trends over time, they must 
be regarded as evidence surrounded with some level of uncertainty.   
 In addition to actually measuring the MMR through work done by the MMEIG, the 
WHO routinely records causes of maternal mortality in order to implement targeted reduction 
methods.  In 2006, the WHO examined a total of 24 datasets (a total of 35,197 maternal deaths) 
and found that hemorrhage and hypertensive disorders contributed to maternal mortality more 
than did any other cause worldwide (Khan, Wojdyla, Gülmezoglu, et al. 2006).  Furthermore, 
they found that access to contraception, adequate antenatal care, and prevention of complications 
during pregnancy, labor, and delivery provide the greatest reduction to these mortality rates 
(Campbell and Graham 2006; Carroli, Rooney, and Villar 2001).  Initiatives for improving 
intrapartum care, increasing access to health care facilities, and expanding contraception can 
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reduce the mortality rate (Campbell and Graham 2006; WHO, UNICEF, UNFPA 2015).  
Although intrapartum care was responsible for the greatest reduction in mortality rates, access to 
family planning and preventing unwanted pregnancies can serve as an “effective form of primary 
prevention” for maternal deaths (Campbell and Graham 2006, 1295).    In fact, some estimates 
claim that contraception access can eliminate “between a quarter and two-fifths of maternal 
deaths” if unplanned and unwanted pregnancies are prevented (Campbell and Graham 2006, 
1295). Preventing women from becoming pregnant when pregnancy is not desired can thus 
obviate maternal complications by preventing the pregnancy altogether. 
In general, maternal mortality has been declining worldwide since the WHO pledged to 
reduce maternal mortality in 2000 (WHO, UNICEF, UNFPA 2015).  However, the world did not 
quite reach its ambitious goal worldwide:  The MMR declined by approximately 44% worldwide 
from 1990 to 2015 (from 385 to 216 [United Nations 2015a; WHO, UNICEF, UNFPA 2015]).  
Breaking down this percentage by region, there were significant improvements in Southern Asia 
(a 64% reduction in MMR) and Sub-Saharan Africa (a 49% decline). The WHO cites unmet 
contraceptive need and lack of antenatal care as two areas of improvement to achieve better 
maternal outcomes (United Nations 2015a).  Thus, there is still a great need to continue to reduce 
this mortality rate and improve maternal health outcomes. 
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THE MEXICO CITY POLICY AND MATERNAL HEALTH OUTCOMES: 
A SYSTEMATIC REVIEW 
Although the potential for the MCP to affect maternal morbidity and mortality is great, 
there have been relatively few studies commenting on this phenomenon. The majority of these 
studies have focused on the implications of the policy for contraception access (Mcfarlane 2006).  
Thus, I decided to investigate and review the current literature regarding this policy’s effects on 
maternal morbidity and mortality.  Specifically, I was interested in peripartum morbidity and 
morbidity related to unsafe abortion complications (hemorrhage, infection, and intra-organ 
perforation), as areas with restricted abortion laws correlate with higher abortion-related 
complications (Ganatra, Gerdts, Rossier, et al. 2017).  My key question in performing this 
systematic review was “Does maternal mortality and morbidity (defined as peripartum morbidity 
related to abortion, unsafe abortion, hemorrhage, infection, and intra-organ perforation) in 
developing nations change according to cycles of the Mexico City Policy’s (MCP’s, or Global 
Gag Rule’s) implementation and rescinded?” 
To my knowledge, there exist few comprehensive systematic reviews about the MCP’s 
effect on reproductive outcomes with no current active protocol in place.  I based this systematic 
review on the PRISMA checklist for reporting results in a systematic review, available at 
www.prisma-statement.org. This review included studies among reproductive aged women (15 
to 49 years old) that compared times at which there was MCP implementation to times at which 
the policy was rescinded, as shown in Appendix 1.  I excluded articles investigating United States 
federal policy or articles not discussing international policy because the focus of this current 
review was on international aid.  I included studies that examined outcomes pertaining to 
maternal and peripartum mortality and morbidity.  Specifically, I included abortion as well as 
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hemorrhage, infection, and intra-organ perforation, as these are common complications of unsafe 
abortions (although these complication rates are rare when abortion is performed safely 
[Upadhyay, Desai, Zlidar 2015]).  I included studies conducted between 1985 and present day in 
developing nations as these times coincide with the policy’s life to date.  I included studies 
involving developing countries since these countries are likely to be affected by the MCP.  
Finally, I included a wide range of study designs but excluded non-English studies, case studies, 
and opinion pieces (as this topic is highly politicized). 
On March 14, 2018, I searched the following databases: JSTOR, EMBase, PubMED, 
Global Health, and the Cochrane Library.  I used the following terms: “Mexico City Policy” and 
“Global Gag Rule” alone and then in conjunction with one of the following terms in each 
database: “Mortality,” “Maternal Mortality,” “Abortion,” “Unsafe Abortion,” “Hemorrhage,” 
“Infection,” and “Perforation.”  I used covidence.org systematic review software for data 
compilation.  A search through clinicaltrials.gov was not performed given the inability to carry 
out an adequate randomized controlled trial of this study question.  Furthermore, I conducted an 
additional search for articles cited in multiple articles upon full in text review. 
I imported all studies found in the above four databases to covidence.org.  Through 
Covidence, I removed all duplicate studies.  I screened article relevance based on their titles and 
their abstracts.  At this stage, I removed any articles that were discernable from their titles or 
abstracts top be editorials, commentary, or memos.  After screening, I assessed remaining 
articles for full-text eligibility based on the criteria in Appendix 1. From the remaining articles, I 
recorded the article title, first author, and year for each study included in data extraction.  I then 
extracted the following information from each study: study design, intervention and measure, 
relevant outcome(s), sample size and source population, years studied, and results.  I assessed 
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strengths and weaknesses of each study. I assessed the potential bias (confounding and 
measurement bias) on a “Low,” “Medium,” or “High.”  I then rated each study on a scale of 
“Good,” “Moderate,” or “Poor” quality at the study level.  I did not attempt a combined 
quantification of study results given the heterogeneity of study findings.  
My initial search yielded 524 original articles (once duplicates were removed), as shown 
in Appendix 2.  Initial screening left 47 articles for article examination.  Additionally, I examined 
two articles mentioned in multiple article-reviewed texts but found that their methodologies did 
not include outcomes from the inclusion criteria.  After assessing full text eligibility, I was left 
with two studies for data extraction.  The final two articles used for analysis were Bendavid, 
Avila, and Miller 2011 and Jones 2011.  Appendix 3 shows the study characteristics, risk of bias 
and quality assessment domains, and overall rating.  Both of the studies I included in my 
systematic review were retrospective cohort studies.  Although both studies examined the effects 
of MCP enactment, the study performed by Jones 2011 examined two periods of policy 
implementation and two periods without policy implementation while Bendavid, Avila, and 
Miller 2011 examined one period with MCP enactment and one without policy enactment.  Both 
studies included in this review examine the effects of the policy on abortion in reproductive age 
women in African countries (Bendavid, Avila, and Miller 2011 examines twenty African nations 
while Jones 2011 examines the nation of Ghana only). 
As described in Appendix 3, the odds for an induced abortion (adjusted for woman and 
country characteristics), as derived by Bendavid, Avila, and Miller 2011, are 2.55 (95% CI 1.76 – 
3.71) in a country that has high MCP exposure (or a country receiving United States foreign aid 
greater than the median amount of foreign aid in countries included in the analysis) as compared 
to a country with low MCP exposure.  Similarly, in Ghana, during times of policy 
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implementation, 2.35% more pregnancies ended in abortion than during times without policy 
implementation as concluded by Jones 2011.  Both of these articles have several strengths 
including using multiple methods for deriving exposure to the MCP (Bendavid, Avila, and Miller 
2011), controlling for several concerning confounders, and adjusting their results appropriately 
(adjusting for annual per capita donations as described by Bendavid, Avila, and Miller 2011 or 
using a woman-fixed effects method as was the case in Jones 2011).  However, these articles 
have several limitations including having data that is limited to survey responses from 
participants in the Domestic Household Survey (DHS, Bendavid, Avila, and Miller 2011) and 
making assumptions about abortion estimates (in both articles). Additionally, both articles have 
limited external validity: Bendavid, Avila, and Miller 2011 can only be applied to the twenty 
African countries studied while Jones 2011 can only be applicable to the population in Ghana.  
Given the reduced applicability in Jones 2011 and that results are in the context that unmet 
contraceptive need equates an undesired pregnancy, I gave Jones 2011 an overall “moderate” 
rating and Bendavid, Avila, and Miller 2011 a “good” rating. 
The conclusions both these articles draw is that although abortion actually seems to 
increase under MCP implementation, there is great estimation uncertainty in determining the 
exact number of abortions performed in these regions (Bendavid, Avila, and Miller 2011; Jones 
2011).  Additionally, both articles reiterate that they have limited applicability to countries 
outside of their initial analysis and admit that the lack of proper abortion data forces them to 
make assumptions on what constitutes an induced vs. a spontaneous abortion (Bendavid, Avila, 
and Miller 2011; Jones 2011).   Finally, although neither of these articles have findings specific 
to maternal mortality, they do note that unwanted pregnancies that result from insufficient 
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reproductive health care access can lead to increases in maternal mortality. (Bendavid, Avila, and 
Miller 2011; Jones 2011).    
This systematic review has several limitations.  The first limitation is simply the lack of 
available data.  This systematic review was only able to identify two papers that examined the 
effects of the MCP on maternal morbidity and mortality.  Although many articles discussed that 
the MCP had negative effects on reproductive health outcomes in these populations, few cited 
specific research (and were mainly editorial and opinion pieces).  A possible reason for this lack 
of available data is the fact that many international organizations, fearful of losing funding, 
halted all research on abortion-related outcomes upon enactment of this policy (Coeytaux 1988).   
To increase the study yield, a more detailed analysis might search the references for each full-
text review article by hand.  Furthermore, inclusion of WHO reports and other large databases 
could prove useful (World Health Organization 2008).  Although these reports may not present 
maternal morbidity and mortality in the context of the MCP, an exploration of the data could 
prove useful in examining overall trends of maternal outcomes at times when the policy was 
enacted.  Additionally, it would be prudent to examine the MCP’s effects on morbidity and 
mortality outside the scope of the peripartum.  For instance, several articles were excluded from 
this review that examined the MCP’s effect on contraception access and exposure to sexually 
transmitted infections (Lancet HIV 2017; Philpott, Slevin, Shapiro, and Heise 2010). Thus, one 
could further expand upon this review and consider other disease processes and economical 
outcomes that could come as a result of MCP implementation. 
There is still a great need to examine the implications and effects of this policy on the 
reproductive health in developing countries. Although numerous articles found during this 
systematic review touch on the MCP, few articles dive into the specifics of the policy as it relates 
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to maternal morbidity and mortality.  From the data addressed in this review, there is some 
concern that the MCP has the potential to increase the likelihood of abortion in African countries 
that have a high need for international aid.  But beyond abortion rates, the public health 
implications of the MCP on developing nations remain uncertain, including the effects of the 
MCP on the high MMRs in these regions.  The rest of this study addresses that question.  
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METHODS 
Variables 
Mexico City Policy Enactment 
 I extracted data on exposure to the MCP from the Kaiser Family Foundation (The Kaiser 
Family Foundation 2017).  I verified the dates provided by the Kaiser Family Foundation by 
examining documentation on the United States federal register and through national archives.  I 
divided the years of MCP enactment into a dichotomous variable (with 0 indicating that the 
policy was not in effect and 1 indicating the policy was in effect).  Then, I used this dichotomous 
variable as the independent variable for the final regression model detailed below. 
 
Financial Data and Mexico City Policy Exposure 
I followed a similar protocol for determining exposure to the MCP as demonstrated by 
Bendavid, Avila, and Miller 2011.  On May 13, 2018, I extracted international aid data through 
the Organization for Economic and Cooperation Development (OECD) database available 
through the OECD credit reporting system (OECD n.d.).  Specifically, I collected world data 
from all donors (total) through two sectors: Sector 13020 Reproductive Health Care and Sector 
13030 Family Planning.  For Flow and Flow Type, I chose the Official Development Assistance 
Flow (All Commitments), through All Channels in current prices for all types of aid.  I added 
data Family Planning and Reproductive Health Care data.  I compiled the same data for 
donations from the United States specifically to determine exposure to the MCP.  To calculate 
international aid donated outside of the United States, I subtracted the sum of the aid given from 
the United States from the sum of the aid given from all donors.   I divided international aid by a 
country’s population to determine the amount of foreign aid per capita.  I dichotomized exposure 
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to the Mexico City Policy as “high” and “low” based on the median of United States aid of the 
countries included in my final analysis.  
 
Country and Covariable Analysis 
 I used the published list of the United Nations member states to develop a list of countries 
from which to perform my analysis (United Nations n.d.a).  I then narrowed down my analysis 
using countries only included in the WHO, UNICEF, World Bank Group, and UNPD “Trends in 
Maternal Mortality,” as countries included in this publication had data on maternal mortality 
(WHO, UNICEF, UNFPA 2015).  I further narrowed the scope of my analysis by organizing 
countries into regions and eliminating all countries considered as “developed” nations (WHO 
n.d.; United Nations n.d.b). Finally, I only included countries with financial data available 
through the OECD Creditor Reporting System (OECD n.d.).  
 In my analysis, I decided to control for the following: total fertility rate (TFR), gross 
domestic product (GDP) per capita, total population of each country, skilled birth attendant 
present at time of delivery (SAB), and life expectancy.  I chose these variables as they have been 
shown to affect maternal mortality estimates or can control for the place of residence (WHO, 
UNICEF, UNFPA 2015; Bendavid, Avila, and Miller 2011; WHO, UNICEF, UNFPA 2015).  
On May 6, 2018, I gathered TFR estimates from the UNPD Fertility Indicators, where TFR 
indicated “the average number of live births a hypothetical cohort of women would have at the 
end of their reproductive period if they were subject during their whole lives to the fertility rates 
of a given period and if they were not subject to mortality” (UNPD n.d.).  TFR is expressed as 
the number of live births per woman.  On May 6, 2018, I compiled GDP data from the World 
Bank (PPP, constant 2011 international dollars).  To calculate GDP per capita, I used these data 
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and divided them by global population data from the United States Census Bureau International 
Database downloaded on May 7, 2018.  I also used these population data in my analysis as a 
covariable.   
I assembled data on skilled birth attendant present at the time of delivery (SAB) from 
UNICEF on May 7, 2018.  For each country, I recorded the percentage of deliveries that had 
with a SAB.  Estimates that covered spans of more than 1 year were entered as the same 
percentage for every year of coverage period (for example, if the coverage period lasted from 
2005 to 2010, and the SAB was 50%, then 0.50 would be entered for 2005, 2006, 2007, 2008, 
and 2009).  When coverage periods overlapped, an average of the overlapping year was recorded 
(for example, if two coverage periods overlapped from 1990 to 1996 and 1995 to 2000, then the 
SAB percentage from the first coverage period for 1995 was averaged with the SAB percentage 
for the year 1995 within the second coverage period).  Years coded as 9999 (indicating an 
unknown year) were not used.   
To further control for variations for place of residence, I compiled life expectancy data 
from the World Bank database on May 8, 2018.  After assembling all covariables, I calculated 
the mean of each variable per year for each region given the large amount of missing data from 
individual countries for varying covariables.  I analyzed the regions as a whole (for example, the 
mean of each variable for all nations in the African region were taken together for statistical 
analysis).  
 
Outcome Measurements: Maternal Mortality Data 
 On May 6, 2018, I collected maternal mortality data from the Trends in Maternal 
Mortality: 1990 to 2015, provided by the WHO, UNICEF, UN Population Fund (UNFPA), 
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World Bank Group, UNPD (WHO, UNICEF, UNFPA 2015).  Of these countries, I excluded 
countries considered by the WHO as developed nations and countries with territorial or debated 
status.  I used the mean MMR of each region for data analysis to examine the role of the MCP on 
MMR on the region rather than for each individual country. Because maternal mortality has been 
steadily decreasing over time, and thus a comparison of mortality data between different 
administrations in time may not accurately reflect the change in policy but rather wider global 
trends, I decided to compare the percent change of the MMR by year with MCP enactment 
without MCP enactment.   I calculated percent change in MMR (cMMR) by subtracting the latter 
year from the former and then dividing by the former and multiplying by 100.  For instance, to 
calculate the percent change of the MMR from 1990 to 1991, I subtracted the MMR of 1991 
from 1990, divided by the MMR of 1990, and then multiplied this result by 100.  A positive 
cMMR meant that there was a reduction in MMR from one year to another, and a more positive 
estimate that there was a greater reduction in MMR.  Similarly, a negative cMMR indicated an 
increase in MMR. 
 
Statistical Analysis 
I performed all calculations and statistical analysis in Stata Version 15 (StataCorp. 2017. 
Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC).  First, I examined 
the variable ranges, missing data points, and distributions.  I then assessed collinearity of the 
variables with Spearman’s Rank test using a collinearity threshold defined as > |0.90|.  I then 
turned my attention to multivariate analysis to determine if exposure to the MCP affects cMMR.  
I ran unadjusted, fully adjusted, and partially adjusted multivariate linear regressions given the 
continuous outcome variable (cMMR).  Knowing that the Stata software removes observations 
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with missing variables, I developed a partially adjusted regression model by removing the 
covariates with the largest number of missing variables: per capita international aid outside of the 
United States and GDP.  I examined the MCP effects on cMMR using all mean data and 
covariates, as well as by region.  I interpreted the outcome of my analysis as the difference in 
cMMR, or that during times of MCP enactment, the percent change in the maternal mortality 
ratio was either greater than or less than the percent change of MMR during times without MCP 
enactment by “X percentage points.”  I then stratified my data by MCP exposure and examined 
MCP effects on cMMR on all regions based on MCP exposure (high or low).  All covariates 
used in my analysis are listed in Appendix 4. 
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RESULTS 
Mexico City Policy Enactment 
 Searches of the Federal Register and presidential archives yielded the following years for 
enactment of the Mexico City Policy: 1985 – 1992, 2000, 2001 – 2008 (Reagan Administration 
1984; 106th Congress; 66 FR 17301).  Years in which presidents revoked the Mexico City Policy 
were: 1993 – 1999, 2000 – 2001, 2009 – 2017 (Clinton Presidential Materials Project; 74 FR 
4903; 82 FR 8495).  Although the policy was enacted in October 1999, it was only enacted for 3 
months and thus 1999 was considered a year “without the policy.”  The policy was then enacted 
through the year 2000 until October of that year, and thus 2000 is considered a year “with the 
policy” for this analysis. 
 
Exposure to the Mexico City Policy 
 The median per capita financial assistance from the United States across all countries 
included in the analysis was 0.534 as shown in Table 1. There were 27 countries with “low” 
MCP exposure and 27 countries with “high” MCP exposure.  In the African region, 13 out of 21 
countries had mean per capita financial assistance above the median.  The Asian, Western 
Pacific, and Eastern Mediterranean regions had a combined 6 out of 14 countries with high 
exposure to the MCP. The European region had 2 out of 9 countries falling within the high 
exposure category.  Finally, 6 out of 10 countries in the American and Caribbean region had high 
MCP exposure. 
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Countries Included in Analysis 
The MMR data from the Trends in Maternal Mortality: 1990 to 2015, provided by the 
WHO, Unicef, UNFPA, World Bank Group, UN Population Division (WHO, UNICEF, UNFPA 
2015) extend from the years 1985 to 2015.  Of the 195 countries recognized by the United 
Nations, MMR data included 183 of these countries and excluded 12 countries with populations 
less than 100,000 (Seychilles, Antigua and Barbuda, Andorra, Dominica, Marshall Islands, Saint 
Kitts and Nevis, Liechtenstein, Monaco, San Marino, Palau, Nauru, Tuvalu), as shown in Figure 
1.  Of these countries, I excluded 36 countries considered by the WHO to be developed nations 
(Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Cyprus, Czech Republic, Denmark, 
Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Latvia, 
Lithuania, Luxembourg, Malta, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, 
Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom, United States).  Additionally, 
I excluded 3 entities (Palestine, Puerto Rico, Guam) because of their territory or debated status.  
From the remaining 144 countries, 54 had financial assistance data available through the OECD 
database and were included in the final analysis.   
 
Mean Maternal Mortality Ratio (MMR) and Covariates Used 
 Table 2 shows the mean MMR for the regions included in the analysis (Africa; Asia, 
Western Pacific, Eastern Mediterranean; Europe; America and the Caribbean) and the global 
mean MMR for the 54 countries included in the analysis.  Figure 2 shows the MMR and 
illustrates that all MMRs are downtrending from 1985 through 2015.  Table 3 shows the percent 
change in MMR (cMMR) for each region and on a global scale.  Because these were calculated 
with the earlier year subtracting the later year, a positive percent change means a decrease by 
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X% during that year.  A negative percent change means that there was an overall increase in 
MMR during the time period of analysis.  Table 4, 5, 6, 7 show the covariables for each region 
and Table 8 shows the mean international donations per capita per region. 
 
Effects of the Mexico City Policy on MMR 
 Table 9 shows the difference in the percent change in MMR (cMMR) during times of 
MCP enactment and times without MCP enactment. The unadjusted difference in cMMR 
comparing years when the MCP was enacted and years that it was not was for all regions was not 
significant at 0.32% (95% CI -0.38, 1.03; p>0.05).  This estimate means that for the years in 
which the MCP was enacted, there was a 0.32% decrease in MMR (the number of maternal 
deaths per 100,000 live births) as compared to years without MCP enactment (although not 
significant).  As illustrated in Table 9, when adjusted for population, skilled birth attendant at 
delivery, per capita international aid from sources other than the United States, GDP, total 
fertility rate, and life expectancy of each region, this estimate decreases to a 0.07% change in 
MMR (95% CI -0.64, 0.78; p>0.05).  Of note, this estimate only includes the years from 1995 to 
2014, and excludes 2004 and 2006.  Thus, this estimate includes 11 years without the policy 
(1995 – 1999 and 2009 – 2014) and 7 years with the policy (2000 – 2003, 2005, 2007 – 2008).  
When adjusted for the same measures excluding GDP and per capita international aid outside of 
the United States, the difference in cMMR is 0.78% (95% CI 0.21, 1.35; p<0.05).  This measure 
was significant and means that during policy enactment during the time period of 1986 through 
2014, the percent change in MMR was greater, at 0.78%, than in times without policy enactment.  
Similar results were seen in the African region and the Asian, Western Pacific, and Eastern 
Mediterranean region, as shown in Table 7.  There were significant differences in the partially 
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adjusted difference in cMMR for these regions: The African region had a 0.99% increase in 
cMMR, meaning that during policy enactment, there was a 0.99% increase in percent change 
(and thus a greater reduction) in MMR (95% CI 0.39, 1.59; p<0.05); In the Asian, Western 
Pacific, and Eastern Mediterranean region, there was a 0.42% increase in cMMR, or that there 
was an increase of 0.42% in cMMR during MCP placement in this region (95% CI 0.06, 0.77; 
p<0.05). 
 In the European region, the difference in cMMR was negative during times of MCP 
enactment (when adjusted for population, skilled birth attendant at delivery, total fertility rate, 
and life expectancy of each region) as shown in Table 9.  This negative result means that during 
policy enactment, there was actually an increase in MMR.  During times of policy enactment, the 
difference cMMR was -5.49% (95% CI -8.97, -2.01; p<0.005).  This estimate means that during 
times of policy enactment, cMMR was actually higher than during times without the MCP (and 
thus there was a greater MMR during times of policy enactment than times without enactment). 
 
Effects of the MCP on MMR Stratified by MCP Exposure 
 Upon further analysis examining the effects of the MCP on MMR by region and exposure 
to international aid, I found significant changes in multiple areas as demonstrated in Table 10.  
The unadjusted change in cMMR was significant only in areas of MCP low exposure in the 
Asian, Western Pacific, and Eastern Mediterranean regions at 0.26 (95% CI 0.08, 0.45; p<0.05).  
This means that during times of policy enactment, when not adjusted for other variables, the 
difference in the percent change in MMR (cMMR) was lower than during times without policy 
enactment. 
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 There was no significant difference in any of the fully adjusted models except for areas of 
low MCP exposure in the African region (adjusting for population, skilled birth attendant at 
delivery, per capita international aid from sources other than the United States, GDP, total 
fertility rate, and life expectancy).  In this region, cMMR increased by 1.37%, meaning that the 
change in MMR was greater during this time period that during times without policy enactment 
(95% CI 0.30, 2.44; p<0.05).  This analysis only included 4 years with the policy (2000 – 2001, 
2007 – 2008) and 7 years without the policy (1999, 2009 – 2014). 
 The majority of the partially adjusted models had significant differences in the difference 
in cMMR between years with the MCP and years without the policy.  When adjusted for 
population, skilled birth attendant at delivery, total fertility rate, and life expectancy, the 
difference in cMMR was 2.67 percentage points in areas of high MCP exposure (95% CI 1.49, 
3.84; p<0.005) and by 0.69 percentage points in areas of low MCP exposure (95% CI 0.06, 1.33; 
p<0.05).  Similar results appear in the African region and in the Asian, Western Pacific, and 
Eastern Mediterranean regions.  In the African Region, I found that cMMR increased during 
times of MCP enactment in countries with both high exposure (cMMR 0.91; 95% CI 0.20, 1.62; 
p<0.05) and low exposure (cMMR 1.11; 95% CI 0.44, 1.78; p<0.005) when adjusted population, 
skilled birth attendant at delivery, total fertility rate, and life expectancy.  Controlling for the 
same variables, similar results were seen in the Asian, Western Pacific, and Eastern 
Mediterranean region: there was an increase in cMMR in both nations of high MCP exposure 
(cMMR 0.62; 95% CI 0.02, 1.22; p<0.05) and low MCP exposure (cMMR 0.30; 95% CI 0.09, 
0.51; p<0.05). 
 Similar to Table 9, Table 10 also illustrates the differences in cMMR during MCP 
enactment seen in the European region.  In countries with low MCP exposure, there was a 
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significant decrease in cMMR during times of MCP enactment when adjusted for population, 
skilled birth attendant at delivery, total fertility rate, and life expectancy (cMMR -5.81; 95% CI -
10.01, -1.60; p<0.05).  This estimate means that during times of MCP enactment, MMR actually 
increased over times without MCP enactment in the European countries included in this analysis.  
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DISCUSSION AND CONCLUSION 
 Here, I examined the role that the Mexico City Policy (MCP) played in maternal 
mortality ratios (MMR, or the number of maternal deaths in a population per 100,000 births) in 
developing nations.  Because MMR has generally fallen since the birth of this policy in 1985, I 
examined the percent change in MMR (cMMR) during time periods with policy enactment and 
periods without policy enactment.  Thus, the results of this study examine how the cMMR 
changes between these different periods. 
 My analysis showed that effects of the MCP on the change in the cMMR varied from 
region to region and between high MCP exposure and low MCP exposure areas.  This study does 
suggest that when controlled for population, skilled birth attendant at delivery, total fertility rate, 
and life expectancy, there was a significant difference in cMMR during MCP enactment, and that 
there was a greater reduction in MMR during times of policy enactment than times without 
policy enactment in African and Asian developing regions.  However, this study also suggests 
that while controlling for the same variables, there was actually an increase MMR during times 
without the MCP in European regions.  
 The magnitude of the results is important to consider.  When examining the differences in 
cMMR with and without MCP enactment in the African Region, for example, a difference of 
<1%, although statistically significant here, may not be clinically significant at a population 
level.  For instance, the average percent change per year during a time of no MCP enactment 
(2009 – 2014) was 2.75% (average MMR and during a time of MCP enactment was 3.59% (2000 
– 2008).  Thus, the difference in the percent change is 0.83%.  This means that there was a 
greater reduction in MMR during policy enactment (2000 – 2008).  However, less than 1% 
change may be attributed to other factors not controlled for in this analysis and may be more 
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attributable to random chance rather than the MCP (as detailed below).  In comparison, in the 
European region there was a difference of -5.49% in cMMR during times of policy enactment as 
compared to times without policy enactment. The negative difference in percent change shown in 
the European region indicates that there was actually an increase in percent change (rather than a 
reduction), or that MMR increased during times of MCP enactment (by 5.49%).  This larger 
value indicates that a more substantial change at a population level may have taken place 
between times of MCP enactment and times without MCP enactment in the European region. 
 There are a couple of explanations for the results of this study.  First, this study used 
MMR as its dependent variable. As discussed previously, this measure is heavily dependent on 
the ability of researchers to measure maternal mortality.  In some areas, mortality may not have 
been as accurately measured (WHO, UNICEF, UNFPA 2015).  Particularly in countries with a 
higher percentage of its population living in rural areas, mortality measures may not be as readily 
available for analysis (WHO, UNICEF, UNFPA 2015).  Furthermore, MMR as measured by the 
MMEIG is different from the Maternal Mortality Rate.  Maternal Mortality Rate is the number of 
women that die out of the total number of reproductive age women in a given area per 100,000 
women (Morse, 2014).  Thus, the estimate of MMR may not as accurately represent maternal 
deaths if the maternal death was not associated with a live birth (such as a death being due to an 
abortion or miscarriage).   
Another possible explanation for the results of my analysis is that the MMR fell 
significantly during the early 2000s upon declaration of the MDGs, regardless of MCP 
enactment (WHO, UNICEF, UNFPA 2015).  Thus, some of the changes seen in cMMR could 
actually be attributed to global efforts to lower maternal mortality, as opposed to the MCP.  
Similarly, changes in MMR in the “all regions” category may have been more heavily influenced 
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by changes in the African and Asian region given that these areas had more countries to 
influence the means of all the covariables.  Moreover, the fact that there were more significant 
estimations found in regions with low MCP exposure as compared to high MCP exposure is 
interesting in that perhaps the resulting MMR are not simply due to MCP exposure alone but to a 
multitude of other factors.   
 Another explanation for the regional differences shown here could be the characteristics 
of the regions as they pertain to maternal care.  For instance, African and Latin American 
countries tend to have the highest rates of unsafe abortion, which can ultimately lead to higher 
complication rates and more maternal deaths.  These areas tend to have less access to skilled 
providers during labor and delivery, antenatal care, and contraception (Camargo, Santana, 
Cecatti et al. 2011; Glasier, Gülmezoglu, Schmid et al. 2006; World Health Organization 2012; 
Melese, Habte, Tsima et al. 2017).  Further, African countries, particularly eastern African 
countries, have the highest proportion of unsafe-abortion-related maternal deaths.  In fact, the 
WO estimated a mortality of 470 women per 100,000 unsafe abortions (World Health 
Organization 2012, Table 2).  But abortion-related deaths are subject to great uncertainty: a 
woman may die from hemorrhage and sepsis, but it may be unclear if these complications were a 
result of an unsafe abortion or another cause (if providers were unsure if the woman was 
pregnant at the time of death and that she underwent an unsafe abortion [Haddad and Nour 2009; 
Khan, Wojdyla, Gülmezoglu, et al. 2006]).   Similarly, Khan Wojdyla, and Gülmezoglu 
attributed a large percentage of maternal deaths (16.7%) in African nations to “other indirect 
causes” of unclear etiology (Khan, Wojdyla, Gülmezoglu, et al. 2006, Table 1).  Thus, the results 
of this analysis must be considered in light of the practices and characteristics of each region. 
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There were also several limitations of this study.  The first was in availability of data.  Of 
the 144 countries considered to be “developing” by the WHO, this study only captured 54 of 
them.  Furthermore, more extensive analysis with all covariables was only able to capture a small 
part of each region. Thus the applicability may be lower in the scope of countries represented by 
this study.  It is also important to note that my analysis used TFR as a proxy for gravidity, which 
could underestimate the number of pregnancies (by not accounting for pregnancies ending in 
abortion).  Other variables that could contribute to MMR should be examined such as access to 
family planning services and availability of prenatal care.  Due to limited availability of data for 
the countries selected in my analysis, I did not include these variables.  Prevention of anemia 
during pregnancy and delivery in a health care facility could also be examined as possible 
covariables (particularly for care during obstructed labor and prevention of infection, [Campbell 
and Graham 2006]).  Moreover, as some countries did not have data available for every year, it 
may be more beneficial to examine time periods over two to five years in order to capture more 
data as opposed to on a yearly basis.  It is also important to consider these factors in light of the 
different abortion policies in these countries: both national policies affecting the legality of 
abortion practices and international policies affecting funding of reproductive health care.   
International and national policies could ultimately affect the reporting of maternal mortality and 
abortion-related mortality and thus limit the scope of the data available for analysis.  Thus, there 
is a whole host of variables one could consider in exploring this data even further. 
 Although a direct link between enactment of the Mexico City Policy and maternal 
mortality cannot be drawn, this analysis can shed some light on the issue.  There is great 
disparity among different regions in exposure to international aid from the United States.  This 
exposure has the power to affect access to health care and ability for women to control their 
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contraception.  However, public policy has the power to improve or exacerbate health outcomes.  
Through careful analysis, we should examine the policies we put in place in order to better the 
health outcomes for the entire population.  The MCP is a policy that has not been enacted with 
evidence-based practices in mind, and the United States should think carefully before enacting 
this policy again. 
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FIGURES 
Figure 1. Flowchart Outlining Country Inclusion For Data Analysis. 
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SOURCES: 
a United Nations. “Member States.” United Nations. http://www.un.org/en/member-states/. Note that Palestine and 
the Holy See are not included as Members of the United Nations but included in the country totals. 
b WHO, UNICEF, UNFPA, World Bank Group, and the UN Population Division. 2015. “Trends in Maternal 
Mortality: 1990 to 2015.” http://www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-
2015/en/.  
c United Nations. “World Economic and Situation Prospects 2014: Country Classification.” United Nations. 
http://www.un.org/en/development/desa/policy/wesp/wesp_current/2014wesp_country_classification.pdf 
d Organization for Economic Cooperation and Development (OECD) Creditor Reporting System. Donor: United 
States, Flow: Official Development Assistance, All Channels, Type: Commitments, Type of Aid: All Types, 
Total. Current Prices. https://stats.oecd.org/Index.aspx?DataSetCode=CRS1 
e World Health Organization. “WHO Regional Offices.” WHO. http://www.who.int/about/regions/en/ 
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Figure 2. Maternal Mortality Ratio (MMR), 1985-2015. 
 
 
SOURCE: WHO, UNICEF, UNFPA, World Bank Group, and the UN Population Division. 2015. “Trends in Maternal Mortality: 1990 to 2015.” 
http://www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-2015/en/.
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TABLES 
Table 1. Financial Assistance for Family Planning and Reproductive Health Services (per capita) 
from the United States between 2009 and 2015. 
Country 
Total Financial 
Assistance for FP 
& RHC in USDa 
Mean 
Population 
Mean Per Capita 
Financial Assistance 
in USDb 
Exposure to 
MCPc 
Africa 
Angola 3634571.43 24472698.43 0.148515352 Low 
Benin 5295089.43 9608308 0.551094889 High 
Burundi 4506820.67 9758450.29 0.461837744 Low 
Democratic 
Republic of 
Congo 
26284448.14 73642177.71 0.356921114 Low 
Ethiopia 39417282.43 91336013.14 0.431563422 Low 
Ghana 12759810.43 24666971.43 0.517283221 Low 
Guinea 5433451.57 10899791.14 0.498491347 Low 
Kenya 25801744.14 42925813.57 0.60107758 High 
Liberia 17631843.14 4100332.43 4.300100894 High 
Madagascar 14997614.29 22024133.86 0.680962729 High 
Malawi 17593963.71 16280733.86 1.080661589 High 
Mali 13916144.29 15421782.43 0.902369382 High 
Mozambique 10240833.57 1312628.57 7.801775608 High 
Nigeria 43303361.86 16874917 3.896906886 High 
Senegal 14496209.86 12979556.57 1.116849391 High 
Sierra Leone 500000 5494715.43 0.090996523 Low 
South Sudan 18788498 10585544.14 1.774920377 High 
Tanzania 26017799.71 46976214 0.553850502 High 
Uganda 25624648.14 33715525.14 0.760025182 High 
Zambia 16106637.71 13841295.71 1.163665458 High 
Zimbabwe 4984325.57 12989088.29 0.383731749 Low 
Asia 
Bangladesh 41726182.43 149827685.3 0.278494474 Low 
India 28990227.71 1204727554 0.024063721 Low 
Indonesia 20367756.5 248515863.3 0.081957571 Low 
Nepal 22472265.86 27493563.71 0.817364605 High 
Timor-Leste 3385502.86 1144762.14 2.957385408 High 
Western Pacific 
Cambodia 11583985.86 14955274.14 0.774575293 High 
Philippines 20436544.71 96246834.71 0.21233472 Low 
Europe 
Albania 1534500 3003987.14 0.510821094 Low 
Armenia 2772120.4 3066276.71 0.904067264 High 
Azerbaijan 2859674.33 9493782.57 0.301215486 Low 
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Georgia 5326318 4922385.86 1.082060236 High 
Kazakhstan 406116.67 17516779.14 0.023184437 Low 
Tajikistan 2278528 7769390 0.293269871 Low 
Turkmenistan 674000 5056362.71 0.133297399 Low 
Ukraine 2448830.67 45367985.71 0.053977064 Low 
Uzbekistan 423037 28397974.29 0.014896732 Low 
Americas 
Bolivia 10066030.2 10289253 0.978305247 High 
Dominican 
Republic 2312747.67 10086854.43 0.229283339 Low 
El Salvador 3451842.75 6088647.43 0.566930963 High 
Guatemala 10527776 14098572.29 0.746726391 High 
Haiti 28604062.43 9841695.71 2.906416055 High 
Honduras 3572599.43 8293866.71 0.43075197 Low 
Mexico 17617 117189969.3 0.000150329 Low 
Nicaragua 3967733.25 5726382.57 0.692886513 High 
Paraguay 4299598 6539677.29 0.657463329 High 
Peru 6167781.17 29548006.14 0.208737643 Low 
Eastern Med 
Afghanistan 84340594.86 30468159.86 2.768155191 High 
Egypt 6846903.5 85606908.57 0.079980735 Low 
Iraq 22099970 33213749.86 0.665386176 High 
Jordan 25252164.57 7716843.86 3.272343595 High 
Pakistan 63899479.43 190285001.9 0.335809332 Low 
Sudan 11985400 34232330.57 0.350119311 Low 
Yemen 6342417 24628306.14 0.257525506 Low 
SOURCES: 
Total Financial Assistance: Organization for Economic Cooperation and Development (OECD) Creditor Reporting 
System. Donor: United States, Flow: Official Development Assistance, All Channels, Type: Commitments, 
Type of Aid: All Types, Total. Current Prices. https://stats.oecd.org/Index.aspx?DataSetCode=CRS1 
Mean population: United States Census Bureau International Database, Midyear population and density data. 
https://www.census.gov/data-tools/demo/idb/informationGateway.php. 
 
aTotal Financial Assistance calculated by summing the total aid for reproductive health care and family planning. 
bPer capita assistance calculated by dividing total United States Assistance by each country’s population. 
cExposure to the Mexico City Policy determined by calculating the median per capita United States assistance of all 
countries included in analysis, 0.534 with high exposure indicating above the median and low exposure 
indicating below the median. 
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Table 2. Mean Maternal Mortality Ratio (MMR) for All Countries Included in Analysis and By 
Region, 1985 – 2014. 
Year All Countries Africa 
Asia, 
Western 
Pacific, 
Eastern Med 
Europe Americas 
1985 697.37 1122.59 728.67 82.86 313.65 
1986 679.48 1107.24 696.88 79.12 297.15 
1987 662.22 1091.16 662.84 75.40 288.72 
1988 644.93 1074.78 630.71 72.15 277.67 
1989 629.43 1059.84 602.10 70.85 266.57 
1990 616.32 1048.96 579.34 66.19 254.66 
1991 608.89 1046.89 558.14 65.03 249.61 
1992 603.59 1048.27 541.10 67.22 239.98 
1993 597.50 1045.14 522.51 71.92 235.48 
1994 587.77 1038.92 501.39 69.43 227.79 
1995 574.10 1020.55 480.58 66.96 223.89 
1996 560.19 1000.40 462.42 63.97 219.25 
1997 544.24 977.06 444.05 59.30 212.01 
1998 529.04 954.00 425.52 54.68 208.46 
1999 512.50 931.98 407.51 50.23 194.59 
2000 497.73 908.63 391.13 47.68 189.10 
2001 483.07 885.10 373.68 46.06 185.29 
2002 466.58 858.86 355.47 44.05 178.64 
2003 449.37 828.40 338.88 41.87 174.83 
2004 430.42 790.48 323.23 39.68 176.04 
2005 410.60 753.62 307.73 39.50 168.23 
2006 393.69 721.27 292.43 37.60 168.01 
2007 378.71 696.95 276.87 36.48 161.00 
2008 364.12 670.47 262.63 35.85 158.32 
2009 353.62 652.46 249.97 34.20 158.67 
2010 340.92 633.47 237.72 33.03 148.16 
2011 329.62 613.71 225.91 31.81 146.27 
2012 318.98 597.19 215.54 31.10 138.64 
2013 310.25 580.78 206.37 30.30 139.53 
2014 301.71 567.14 197.06 29.66 135.65 
SOURCES: 
MMR: WHO, UNICEF, UNFPA, World Bank Group, and the UN Population Division. 2015. “Trends in Maternal 
Mortality: 1990 to 2015.” http://www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-
2015/en/.  
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Table 3. Mean Percent MMR Change by year (cMMR) for All Countries Included in Analysis 
and By Region, 1986-2014. a 
Year All Countries Africa 
Asia, 
Western 
Pacific, 
Eastern Med 
Europe Americas 
1986 2.57 1.37 4.36 4.52 5.26 
1987 2.54 1.45 4.88 4.69 2.84 
1988 2.61 1.50 4.85 4.32 3.83 
1989 2.40 1.39 4.54 1.80 4.00 
1990 2.08 1.03 3.78 6.58 4.47 
1991 1.21 0.20 3.66 1.74 1.98 
1992 0.87 -0.13 3.05 -3.37 3.86 
1993 1.01 0.30 3.44 -6.98 1.88 
1994 1.63 0.60 4.04 3.45 3.26 
1995 2.33 1.77 4.15 3.56 1.71 
1996 2.42 1.97 3.78 4.47 2.08 
1997 2.85 2.33 3.97 7.30 3.30 
1998 2.79 2.36 4.17 7.80 1.68 
1999 3.13 2.31 4.23 8.13 6.65 
2000 2.88 2.51 4.02 5.09 2.82 
2001 2.94 2.59 4.46 3.40 2.02 
2002 3.41 2.96 4.87 4.35 3.59 
2003 3.69 3.55 4.67 4.96 2.13 
2004 4.22 4.58 4.62 5.22 -0.69 
2005 4.61 4.66 4.79 0.46 4.43 
2006 4.12 4.29 4.97 4.80 0.13 
2007 3.80 3.37 5.32 2.97 4.17 
2008 3.85 3.80 5.14 1.74 1.67 
2009 2.88 2.69 4.82 4.60 -0.22 
2010 3.59 2.91 4.90 3.44 6.62 
2011 3.31 3.12 4.97 3.68 1.28 
2012 3.23 2.69 4.59 2.22 5.22 
2013 2.74 2.75 4.26 2.59 -0.64 
2014 2.75 2.35 4.51 2.09 2.78 
SOURCES: 
MMR: WHO, UNICEF, UNFPA, World Bank Group, and the UN Population Division. 2015. “Trends in Maternal 
Mortality: 1990 to 2015.” http://www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-
2015/en/.  
aCalculations for cMMR performed as described by first author. 
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Table 4. Mean Covariates for Countries included in the African Region, 1985-2014.a 
Year 
Total 
Fertility 
Rate 
GDP Population 
Percent of Deliveries 
with a Skilled Birth 
Attendant Present 
Life Expectancy 
(years) 
1985 6.73 . 15338960.43 1.47c 48.02 
1986 6.73 . 15765196.29 3.56d 48.19 
1987 6.73 . 16210950.71 14.99e 48.33 
1988 6.73 . 16669201.48 17.15f 48.44 
1989 6.73 . 17142212.86 17.15f 48.52 
1990 6.42 1563.73b 17621374.00 17.77g 48.57 
1991 6.42 1537.31b 18138053.95 22.63h 48.61 
1992 6.42 1442.19 b 18660111.90 17.51i 48.65 
1993 6.42 1381.72b 19165000.81 18.21j 48.69 
1994 6.42 1356.98b 19702085.19 29.23k 48.75 
1995 6.14 1365.04b 20271574.05 32.46l 48.84 
1996 6.14 1407.54b 20788358.81 33.51m 48.97 
1997 6.14 1431.14b 21295377.38 29.44n 49.14 
1998 6.14 1454.55b 21847046.95 32.05o 49.36 
1999 6.14 1466.99b 22437113.19 32.45p 49.63 
2000 5.86 1473.86b 23044251.14 35.12q 49.99 
2001 5.86 1496.06b 23672534.86 35.41r 50.45 
2002 5.86 1476.76b 24328486.48 41.21s 51.01 
2003 5.86 1482.62b 25009066.81 42.52t 51.66 
2004 5.86 1560.66b 25707681.52 40.37u 52.40 
2005 5.56 1608.64b 26426589.81 45.50v 53.21 
2006 5.56 1678.59b 27171149.00 46.84w 70.18 
2007 5.56 1766.59 27933949.71 36.65x 70.48 
2008 5.56 1998.30 28716455.57 45.44y 70.77 
2009 5.56 2027.62 29518907.52 50.00z 71.07 
2010 5.17 2089.60 30346769.52 46.35aa 71.36 
2011 5.17 2134.69 31202420.29 49.04bb 71.66 
2012 5.17 2113.19 32067762.33 50.92bb 71.94 
2013 5.17 2187.88 32944496.00 48.57cc 72.22 
2014 5.17 2235.79 33841191.33 31.46dd 72.48 
SOURCES:  
MMR: WHO, UNICEF, UNFPA, World Bank Group, and the UN Population Division. 2015. “Trends in Maternal 
Mortality: 1990 to 2015.” http://www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-
2015/en/.  
TFR: UN Population Division. World Population Prospects 2017, 
https://esa.un.org/unpd/wpp/Download/Standard/Fertility/. 
GDP per capita: World Bank Databank, World Development Indicators. PPP (constant 2011 international $) 
http://databank.worldbank.org/data/reports.aspx?source=world-development-indicators# 
Population: United States Census Bureau International Database, Midyear population and density data. 
https://www.census.gov/data-tools/demo/idb/informationGateway.php. 
Percent SAB: Unicef, WHO joint database on skilled attendant at delivery. https://data.unicef.org/topic/maternal-
health/delivery-care/. Data manipulated by first author as indicated in methods. 
a Unless otherwise indicated below, all countries included in averages provided. 
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b Excludes South Sudan 
c Nigeria 
d Tanzania, Nigeria 
e Guinea, Madagascar, Malawi, Senegal, Tanzania, Zambia, Nigeria 
f Guinea, Kenya, Madagascar, Malawi, Senegal, Tanzania, Zambia, Nigeria 
g Ghana, Guinea, Kenya, Madagascar, Malawi, Senegal, Tanzania, Zambia 
h Ghana, Guinea, Kenya, Madagascar, Malawi, Senegal, Tanzania, Uganda, Zambia, Zimbabwe 
i Ghana, Kenya, Mali, Senegal, Tanzania, Uganda, Zambia, Zimbabwe 
j Benin, Ghana, Mali, Senegal, Tanzania, Uganda, Zambia, Zimbabwe 
kGhana, Guinea, Liberia, Madagascar, Malawi, Mali, Mozambique, Senegal, Tanzania, Uganda, Zambia, Zimbabwe 
l  Angola, Benin, Ghana, Guinea, Kenya, Liberia, Madagascar, Malawi, Mali, Mozambique, Senegal, Tanzania, 
Uganda, Zambia, Zimbabwe 
m Ghana, Guinea, Kenya, Liberia, Madagascar, Malawi, Mali, Mozambique, Senegal, Tanzania, Uganda, Zambia, 
Zimbabwe, Nigeria 
n Ethiopia, Ghana, Guinea, Kenya, Liberia, Malawi, Mali, Senegal, Tanzania, Uganda, Zambia, Zimbabwe, Nigeria 
o Ethiopia, Ghana, Guinea, Liberia, Madagascar, Malawi, Mali, Mozambique, Senegal, Tanzania, Uganda, Zambia, 
Zimbabwe, Nigeria 
p Burundi, Ethiopia, Ghana, Kenya, Liberia, Madagascar, Malawi, Mali, Mozambique, Senegal, Sierra Leone, 
Tanzania, Uganda, Zambia, Nigeria 
q Democratic Republic of Congo, Ethiopia, Ghana, Guinea, Kenya, Madagascar, Malawi, Mali, Mozambique, 
Senegal, Tanzania, Uganda, Zambia, Zimbabwe, Nigeria 
r Angola, Benin, Ethiopia, Ghana, Guinea, Kenya, Madagascar, Malawi, Mali, Mozambique, Senegal, Tanzania, 
Uganda, Zambia, Zimbabwe, Nigeria 
s Angola, Benin, Democratic Republic of Congo, Ethiopia, Ghana, Guinea, Kenya, Liberia, Madagascar, Malawi, 
Mali, Mozambique, Senegal, Tanzania, Uganda, Zambia, Zimbabwe, Nigeria 
t Angola, Benin, Burundi, Democratic Republic of Congo, Ethiopia, Ghana, Guinea, Kenya, Liberia, Madagascar, 
Malawi, Mali, Senegal, Sierra Leone, Tanzania, Uganda, Zambia, Zimbabwe, Nigeria 
u Angola, Benin, Burundi, Democratic Republic of Congo, Ethiopia, Ghana, Guinea, Kenya, Liberia, Madagascar, 
Malawi, Mali, Senegal, Sierra Leone, South Sudan, Uganda, Zambia, Zimbabwe, Nigeria 
v Angola, Benin, Burundi, Democratic Republic of Congo, Ethiopia, Ghana, Guinea, Kenya, Liberia, Madagascar, 
Malawi, Mali, Senegal, Sierra Leone, South Sudan, Tanzania, Uganda, Zambia, Zimbabwe, Nigeria 
w Angola, Benin, Burundi, Democratic Republic of Congo, Ethiopia, Ghana, Guinea, Kenya, Liberia, Madagascar, 
Malawi, Mozambique, Senegal, Sierra Leone, Tanzania, Uganda, Zambia, Zimbabwe, Nigeria 
x Benin, Burundi, Ethiopia, Ghana, Guinea, Kenya, Madagascar, Malawi, Mozambique, Senegal, Sierra Leone, 
Tanzania, Uganda, Zimbabwe, Nigeria 
y Benin, Burundi, Democratic Republic of Congo, Ethiopia, Guinea, Kenya, Liberia, Madagascar, Malawi, 
Mozambique, Senegal, Sierra Leone, South Sudan, Tanzania, Uganda, Zambia, Zimbabwe, Nigeria 
z Benin, Burundi, Democratic Republic of Congo, Ethiopia, Ghana, Guinea, Kenya, Liberia, Madagascar, Malawi, 
Mozambique, Senegal, Sierra Leone, South Sudan, Tanzania, Uganda, Zambia, Zimbabwe, Nigeria 
aa Angola, Benin, Democratic Republic of Congo, Ethiopia, Ghana, Guinea, Kenya, Liberia, Madagascar, 
Mozambique, Senegal, Sierra Leone, Tanzania, Uganda, Zambia, Zimbabwe, Nigeria 
bb Angola, Benin, Burundi, Democratic Republic of Congo, Ethiopia, Ghana, Guinea, Kenya, Liberia, Madagascar, 
Nigeria, Senegal, Sierra Leone, Tanzania, Uganda, Zambia, Zimbabwe 
cc Angola, Benin, Burundi, Democratic Republic of Congo, Ethiopia, Ghana, Guinea, Kenya, Malwai, Mali, Nigeria, 
Senegal, Tanzania, Uganda, Zambia, Zimbabwe 
dd Angola, Benin, Burundi, Ethiopia, Guinea, Mali, Nigeria, Senegal, Tanzania, Uganda, Zimbabwe 
 
. = missing data 
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Table 5. Mean Covariates for Countries included in the Asian, Western Pacific, and Eastern 
Mediterranean Regions, 1985-2014.a 
Year 
Total 
Fertility 
Rate 
GDP Population 
Percent of Deliveries 
with a Skilled Birth 
Attendant Present 
Life Expectancy 
(years) 
1985 5.70 . 93674519.86 1.34e 56.17 
1986 5.70 . 95759732.21 7.88f 56.81 
1987 5.70 . 97801717.79 8.03f 57.40 
1988 5.70 . 99897930.00 20.47g 57.94 
1989 5.70 . 102030089.14 23.74h 58.45 
1990 5.20 3194.00b 104187957.93 18.37i 58.93 
1991 5.20 2663.11b 106240152.93 17.26j 59.40 
1992 5.20 2849.99b 108457300.21 24.42j 59.87 
1993 5.20 3040.96c 110734900.43 22.70k 60.33 
1994 5.20 3101.98c 113010024.71 21.93k 60.79 
1995 4.79 3178.62c 115278882.86 24.81l 61.26 
1996 4.79 3286.39c 117569342.71 26.23m 61.72 
1997 4.79 3440.85c 119869847.93 26.96n 62.17 
1998 4.79 3585.10c 122166523.71 32.14n 62.61 
1999 4.79 3752.68c 124473103.29 35.27o 63.03 
2000 4.33 3916.53d 126770971.57 38.34p 63.43 
2001 4.33 3987.27d 129079704.86 42.33q 63.83 
2002 4.33 4032.58 131403228.14 40.88r 64.22 
2003 4.33 3840.23 133703854.64 39.64s 64.61 
2004 4.33 4215.29 135955877.79 45.81t 64.99 
2005 3.95 4379.63 138174321.07 51.59u 65.38 
2006 3.95 4584.04 140382845.07 48.59v 65.75 
2007 3.95 4760.85 142504876.14 47.20w 66.12 
2008 3.95 4943.24 144648944.00 44.07x 66.47 
2009 3.95 5048.56 146864291.64 58.25x 66.81 
2010 3.62 5205.67 149056116.00 57.96y 67.13 
2011 3.62 5282.16 151251464.14 57.19z 67.43 
2012 3.62 5503.23 153467881.71 55.68aa 67.72 
2013 3.62 5632.63 155731498.93 48.46bb 68.00 
2014 3.62 5699.93 157986647.79 17.79cc 68.27 
 
SOURCES:  
MMR: WHO, UNICEF, UNFPA, World Bank Group, and the UN Population Division. 2015. “Trends in Maternal 
Mortality: 1990 to 2015.” http://www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-
2015/en/.  
TFR: UN Population Division. World Population Prospects 2017, 
https://esa.un.org/unpd/wpp/Download/Standard/Fertility/. 
GDP per capita: World Bank Databank, World Development Indicators. PPP (constant 2011 international $) 
http://databank.worldbank.org/data/reports.aspx?source=world-development-indicators# 
Population: United States Census Bureau International Database, Midyear population and density data. 
https://www.census.gov/data-tools/demo/idb/informationGateway.php. 
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Percent SAB: Unicef, WHO joint database on skilled attendant at delivery. https://data.unicef.org/topic/maternal-
health/delivery-care/. Data manipulated by first author as indicated in methods. 
 
a Unless otherwise indicated below, all countries included in averages provided. 
b Excludes Cambodia, Timor-Leste, and Afghanistan 
c Excludes Timor-Leste, and Afghanistan 
d Excludes Afghanistan 
e Pakistan only 
f Pakistan, Egypt, Yemen, Indonesia, Nepal 
g Egypt, Jordan, Pakistan, Yemen, Philippines, India, Indonesia, Nepal 
h Egypt, Pakistan, Yemen, Cambodia, Philippines, Bangladesh, India, Indonesia, Nepal 
i Egypt, Yemen, Cambodia, Philippines, Bangladesh, India, Indonesia 
j Egypt, Jordan, Cambodia, Philippines, Bangladesh, Indonesia, Nepal 
k Egypt, Jordan, Cambodia, Philippines, Bangladesh, India, Indonesia, Nepal 
l Egypt, Jordan, Pakistan, Cambodia, Philippines, Bangladesh, India, Indonesia, Nepal 
m Egypt, Jordan, Cambodia, Philippines, Bangladesh, India, Indonesia 
n Egypt, Jordan, Pakistan, Yemen, Cambodia, Philippines, Bangladesh, India, Indonesia, Nepal, Timor-Leste 
o Egypt, Iraq, Jordan, Yemen, Cambodia, Philippines, Bangladesh, India, Indonesia, Nepal, Timor-Leste 
p Afghanistan, Egypt, Iraq, Jordan, Pakistan, Yemen, Cambodia, Philippines, Bangladesh, India, Indonesia, Nepal, 
Timor-Leste 
q Afghanistan, Egypt, Iraq, Jordan, Pakistan, Cambodia, Philippines, Bangladesh, India, Indonesia, Nepal, Timor-
Leste 
r Egypt, Iraq, Jordan, Pakistan, Cambodia, Philippines, Bangladesh, India, Indonesia, Nepal 
s Egypt, Iraq, Jordan, Pakistan, Sudan, Yemen, Cambodia, Philippines, Bangladesh, India, Indonesia, Nepal, Timor-
Leste 
t Afghanistan, Egypt, Iraq, Jordan, Pakistan, Sudan, Yemen, Cambodia, Philippines, Bangladesh, India, Indonesia, 
Nepal, Timor-Leste 
u Afghanistan, Egypt, Iraq, Jordan, Pakistan, Cambodia, Philippines, Bangladesh, India, Indonesia, Nepal, Timor-
Leste 
v Afghanistan, Egypt, Jordan, Pakistan, Yemen, Cambodia, Philippines, Bangladesh, India, Indonesia, Nepal, Timor-
Leste 
w Afghanistan, Jordan, Pakistan, Sudan, Yemen, Cambodia, Philippines, Bangladesh, Indonesia, Nepal, Timor-Leste 
x Afghanistan, Egypt, Iraq, Jordan, Pakistan, Sudan, Yemen, Cambodia, Philippines, Bangladesh, Indonesia, Nepal, 
Timor-Leste 
y Afghanistan, Egypt, Iraq, Jordan, Pakistan, Yemen, Cambodia, Philippines, Bangladesh, India, Indonesia, Nepal 
z Afghanistan, Egypt, Jordan, Pakistan, Yemen, Cambodia, Philippines, Bangladesh, India, Indonesia, Nepal, Timor-
Leste 
aa Afghanistan, Egypt, Iraq, Pakistan, Sudan, Yemen, Cambodia, Philippines, Bangladesh, India, Nepal, Timor-Leste 
bb Afghanistan, Sudan, Cambodia, Bangladesh, India, Indonesia, Nepal, Timor-Leste 
cc Bangladesh, India, Nepal, Timor-Leste 
 
. = missing data 
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Table 6. Mean Covariates for Countries included in the European Region, 1985-2014.a 
Year 
Total 
Fertility 
Rate 
GDP Population 
Percent of 
Deliveries with a 
Skilled Birth 
Attendant Present 
Life 
Expectancy 
(years) 
1985 3.41 . 12380752.44 . 67.39 
1986 3.41 . 12530885.33 . 67.51 
1987 3.41 . 12679242.11 . 67.63 
1988 3.41 . 12824546.33 . 67.54 
1989 3.41 . 12926761.67 . 67.42 
1990 3.02 7059.11 13062331.33 65.06b 67.30 
1991 3.02 6266.82 13182881.00 74.34c 67.07 
1992 3.02 5077.90 13271540.56 63.65b 67.04 
1993 3.02 4505.39 13320481.00 74.50c 66.90 
1994 3.02 3906.55 13324480.56 74.09d 66.82 
1995 2.42 3724.70 13315809.78 83.25e 66.82 
1996 2.42 3791.47 13323184.89 72.11f 66.91 
1997 2.42 3764.04 13324394.11 83.58e 67.24 
1998 2.42 3910.49 13320046.56 94.59g 67.59 
1999 2.42 4159.89 13318861.89 93.21g 67.98 
2000 2.12 4453.53 13322040.33 64.17c 68.18 
2001 2.12 4852.70 13329598.44 84.83h 68.50 
2002 2.12 5185.45 13343782.67 85.29i 68.75 
2003 2.12 5625.42 13362579.78 96.12g 68.95 
2004 2.12 6097.58 13389896.56 95.73g 69.17 
2005 2.17 6730.59 13429800.22 97.25g 69.35 
2006 2.17 7554.82 13475539.89 75.22c 69.60 
2007 2.17 8422.35 13522933.56 75.64j 69.87 
2008 2.17 8901.68 13576332.11 86.88h 70.15 
2009 2.17 8830.28 13641505.89 76.11k 70.63 
2010 2.28 9280.44 13712296.33 76.08k 70.94 
2011 2.28 9750.33 13784575.22 76.40k 71.28 
2012 2.28 10142.83 13860519.22 76.53l 71.55 
2013 2.28 10569.29 13935336.89 87.80l 71.84 
2014 2.28 10912.86 13972087.33 87.74l 72.12 
SOURCES:  
MMR: WHO, UNICEF, UNFPA, World Bank Group, and the UN Population Division. 2015. “Trends in Maternal 
Mortality: 1990 to 2015.” http://www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-
2015/en/.  
TFR: UN Population Division. World Population Prospects 2017, 
https://esa.un.org/unpd/wpp/Download/Standard/Fertility/. 
GDP per capita: World Bank Databank, World Development Indicators. PPP (constant 2011 international $) 
http://databank.worldbank.org/data/reports.aspx?source=world-development-indicators# 
Population: United States Census Bureau International Database, Midyear population and density data. 
https://www.census.gov/data-tools/demo/idb/informationGateway.php. 
Percent SAB: Unicef, WHO joint database on skilled attendant at delivery. https://data.unicef.org/topic/maternal-
health/delivery-care/. Data manipulated by first author as indicated in methods. 
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a Unless otherwise indicated below, all countries included in averages provided. 
b Albania, Armenia, Azerbaijan, Georgia, Kazakhstan, Ukraine 
c Albania, Armenia, Azerbaijan, Georgia, Kazakhstan, Tajikistan, Ukraine 
d Albania, Armenia, Azerbaijan, Kazakhstan, Tajikistan, Ukraine, Uzbekistan 
e Albania, Armenia, Azerbaijan, Kazakhstan, Tajikistan, Turkmenistan, Ukraine, Uzbekistan 
f Albania, Armenia, Azerbaijan, Kazakhstan, Tajikistan, Turkmenistan, Ukraine 
g Albania, Armenia, Azerbaijan, Kazakhstan, Tajikistan, Turkmenistan, Ukraine, Uzbekistan 
h Albania, Armenia, Azerbaijan, Georgia, Kazakhstan, Tajikistan, Ukraine, Uzbekistan 
i Armenia, Azerbaijan, Georgia, Kazakhstan, Tajikistan, Turkmenistan, Ukraine, Uzbekistan 
j Albania, Armenia, Azerbaijan, Georgia, Tajikistan, Ukraine, Uzbekistan 
k Armenia, Azerbaijan, Georgia, Kazakhstan, Tajikistan, Ukraine, Uzbekistan 
l Armenia, Azerbaijan, Georgia, Kazakhstan, Tajikistan, Turkmenistan, Ukraine, Uzbekistan 
 
. = missing data
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Table 7. Mean Covariates for Countries included in the America Region, 1985-2014.a 
Year 
Total 
Fertility 
Rate 
GDP Population 
Percent of 
Deliveries with a 
Skilled Birth 
Attendant Present 
Life 
Expectancy 
(years) 
1985 4.72 . 13751232.60 6.60 61.69c 
1986 4.72 . 14060288.30 21.09 62.24d 
1987 4.72 . 14383471.70 31.88 62.79e 
1988 4.72 . 14706265.50 40.62 63.34f 
1989 4.72 . 15015176.10 42.68 63.88g 
1990 4.25 4871.37b 15329490.90 45.64 64.41h 
1991 4.25 4921.43b 15652768.80 51.27 64.92i 
1992 4.25 5009.53b 15972113.40 51.86 65.41i 
1993 4.25 5145.67b 16290360.60 52.81 65.87i 
1994 4.25 5290.37b 16614008.20 52.87 66.32i 
1995 3.76 5337.64 16933114.60 63.69 66.74j 
1996 3.76 5627.85 17247638.10 64.09 67.14j 
1997 3.76 5837.86 17556530.60 64.58 67.52j 
1998 3.76 5943.45 17855766.70 64.87 67.89j 
1999 3.76 5996.63 18135789.40 67.75 68.24j 
2000 3.30 6099.77 18409441.80 59.15 68.59i 
2001 3.30 6058.26 18684934.50 71.05 68.92j 
2002 3.30 6112.36 18959505.30 67.55 69.25i 
2003 3.30 6159.39 19235839.50 74.30 69.56j 
2004 3.30 6283.23 19511474.30 74.83 69.87j 
2005 2.92 6471.84 19784118.80 74.90 70.18j 
2006 2.92 6753.50 20056631.00 74.32 70.48k 
2007 2.92 7026.12 20335148.90 79.69 70.77l 
2008 2.92 7191.12 20622369.50 80.62 71.07l 
2009 2.92 6986.49 20916441.00 82.51 71.36l 
2010 2.64 7282.79 21190632.60 81.58 71.66l 
2011 2.64 7490.84 21486027.40 75.67 71.94l 
2012 2.64 7647.13 21777630.50 67.73 72.22l 
2013 2.64 7901.81 22061270.70 68.08 72.48l 
2014 2.64 8099.42 22338677.90 68.22 72.74l 
SOURCES:  
MMR: WHO, UNICEF, UNFPA, World Bank Group, and the UN Population Division. 2015. “Trends in Maternal 
Mortality: 1990 to 2015.” http://www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-
2015/en/.  
TFR: UN Population Division. World Population Prospects 2017, 
https://esa.un.org/unpd/wpp/Download/Standard/Fertility/. 
GDP per capita: World Bank Databank, World Development Indicators. PPP (constant 2011 international $) 
http://databank.worldbank.org/data/reports.aspx?source=world-development-indicators# 
Population: United States Census Bureau International Database, Midyear population and density data. 
https://www.census.gov/data-tools/demo/idb/informationGateway.php. 
Percent SAB: Unicef, WHO joint database on skilled attendant at delivery. https://data.unicef.org/topic/maternal-
health/delivery-care/. Data manipulated by first author as indicated in methods. 
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a Unless otherwise indicated below, all countries included in averages provided. 
b Excludes Haiti. 
c Paraguay 
d Dominican Republic, Paraguay, Peru 
e Dominican Republic, Honduras, Nicaragua, Paraguay, Peru 
f Dominican Republic, El Salvador, Honduras, Nicaragua, Paraguay, Peru 
g Dominican Republic, El Salvador, Haiti, Honduras, Nicaragua, Paraguay, Peru 
h Dominican Republic, El Salvador, Guatemala, Haiti, Honduras, Nicaragua, Paraguay, Peru 
i Bolivia, Dominican Republic, El Salvador, Guatemala, Haiti, Honduras, Nicaragua, Paraguay, Peru 
j Bolivia, Dominican Republic, El Salvador, Guatemala, Haiti, Honduras, Mexico, Nicaragua, Paraguay, Peru 
k Bolivia, Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Paraguay, Peru 
l Bolivia, Dominican Republic, El Salvador, Guatemala, Haiti, Mexico, Nicaragua, Paraguay, Peru 
 
. = missing data  
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Table 8. Mean International Donations Per Capita from Countries (Per Region) Outside of the 
United States.a,b 
Year African Region 
Asian, Western 
Pacific, and Eastern 
Mediterranean 
Region 
European 
Region 
America and Caribbean 
Region 
1995 0.052322688c . . . 
1996 . . . 0.016044998hh 
1997 0.001751032d 0.018969374n . 0.028760762ii 
1998 . 0.04007865o . 0.027567223hh 
1999 0.04871097e 0.002526002p . 0.122601714jj 
2000 0.292167622f 0.025180987q 0.009546718x 0.050795234kk 
2001 0.14446035g 0.061729988r 0.013597239y 0.384588185ll 
2002 . 0.001274225n . . 
2003 . 0.006431871s . . 
2004 . . . . 
2005 . 0.000882141t . 0.003950145mm 
2006 . . . . 
2007 0.127932659h 0.312073666u 0.057958897z 0.394684662nn 
2008 0.273287819i 0.372445611v 0.088653129aa 0.504650008nn 
2009 0.558211114j 0.267722726v 0.069697491bb 0.25404505nn 
2010 0.435747038k 0.275346404v 0.209418036cc 0.382133671nn 
2011 0.602064717l 0.564351491v 0.059297919dd 0.35437919oo 
2012 1.167304812l 0.501970341v 0.027992488ee 0.131589072oo 
2013 1.051969791m 0.793410383w 0.042554662ff 0.091678707pp 
2014 0.543860282m 0.38749964w 0.029669478gg 0.074319168rr 
Total Financial Assistance: Organization for Economic Cooperation and Development (OECD) Creditor Reporting 
System. Donor: United States, Flow: Official Development Assistance, All Channels, Type: Commitments, 
Type of Aid: All Types, Total. Current Prices. https://stats.oecd.org/Index.aspx?DataSetCode=CRS1 
Mean population: United States Census Bureau International Database, Midyear population and density data. 
https://www.census.gov/data-tools/demo/idb/informationGateway.php. 
 
aPer capita international assistance from countries other than United States calculated by subtracting the total 
financial assistance of reproductive health care and family planning from the United States from the global 
donations for reproductive health care and family planning for each country, then dividing by the total 
population for each country 
bUnless otherwise indicated below, all countries in each region included in averages provided. 
c Zambia only. 
d Excludes Senegal 
e Ethiopia, Kenya, Mali, Mozambique, Nigeria, Tanzania, Zambia, Zimbabwe 
f Ethiopia, Ghana, Guinea, Kenya, Malawi, Mozambique, Nigeria, Tanzania, Zambia, Zimbabwe 
g Benin, Ghana, Guinea, Madagascar, Malawi, Mali, Mozambique, Senegal, Tanzania, Zambia 
h Democratic Republic of Congo, Ethiopia, Ghana, Guinea, Kenya, Liberia, Madagascar, Malawi, Mali, 
Mozambique, Nigeria, Senegal, Tanzania, Zambia 
i Angola, Benin, Democratic Republic of Congo, Ethiopia, Ghana, Guinea, Kenya, Liberia, Madagascar, Malawi, 
Mali, Mozambique, Nigeria, Senegal, Tanzania, Zambia 
j Excludes South Sudan and Burundi 
k Excludes South Sudan, Sierra Leone, and Burundi 
l Excludes Sierra Leone and Burundi 
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m Excludes Sierra Leone 
n India 
o India, Nepal, Cambodia 
p Bangladesh, India, Indonesia, Nepal, Cambodia 
q Bangladesh, India, Indonesia, Nepal, Cambodia, Egypt 
r Bangladesh, India, Indonesia, Nepal, Cambodia, Philippines, Egypt 
s Philippines, Egypt 
t Egypt 
u Bangladesh, India, Indonesia, Nepal, Timor-Leste, Cambodia, Philippines, Afghanistan, Egypt, Jordan, Pakistan, 
Sudan, Yemen 
v Bangladesh, India , Nepal, Timor-Leste, Cambodia, Philippines, Afghanistan, Egypt, Jordan, Pakistan, Sudan, 
Yemen 
w Bangladesh, India, Indonesia, Nepal, Timor-Leste, Cambodia, Philippines, Afghanistan, Egypt, Jordan, Pakistan, 
Yemen 
x Armenia, Azerbaijan, Georgia, Kazakhstan, Turkmenistan 
y Azerbaijan, Kazakhstan 
z Albania, Armenia, Georgia, Kazakhstan, Tajikistan, Turkmenistan, Ukraine, Uzbekistan 
aa Albania, Armenia, Georgia, Tajikistan, Turkmenistan, Ukraine, Uzbekistan 
bb Albania, Armenia, Azerbaijan, Georgia, Tajikistan, Ukraine, Uzbekistan 
cc Albania, Armenia, Azerbaijan, Georgia, Kazakhstan, Tajikistan, Turkmenistan, Uzbekistan 
dd Armenia, Azerbaijan, Georgia, Kazakhstan, Tajikistan, Ukraine 
ee Georgia, Kazakhstan, Tajikistan 
ff Georgia, Tajikistan 
gg Armenia, Tajikistan 
hh Bolivia, Ecuador, Peru 
ii Bolivia, Ecuador, El Salvador, Peru  
jj El Salvador, Haiti, Honduras, Nicaragua, Peru 
kk Ecuador, Haiti, Honduras, Nicaragua, Peru 
ll Bolivia, El Salvador, Guatemala, Haiti, Honduras, Nicaragua, Peru 
mm Peru 
nn Bolivia, Dominican Republic, El Salvador, Guatemala, Haiti, Honduras, Nicaragua, Paraguay, Peru 
oo Bolivia, Dominican Republic, El Salvador, Guatemala, Haiti, Honduras, Nicaragua, Peru 
pp Bolivia, Dominican Republic, Guatemala, Haiti, Honduras, Peru 
qq Guatemala, Haiti, Honduras 
rr Guatemala, Haiti, Honduras, Mexico, Peru 
 
 
. = missing data 
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Table 9. Percent Change in Maternal Mortality Ratio (cMMR) during Enactment of the Mexico 
City Policy through Multivariable Regression. 
 Unadjusted ΔcMMR (95% CI)a 
Fully Adjusted 
ΔcMMR 
(95% CI)b 
Partially Adjusted 
ΔcMMR 
(95% CI)c 
All regions and 
countries 
0.32 
(-0.38, 1.03) 
0.07d 
(-0.64, 0.78) 
0.78* 
(0.21, 1.35) 
African Region 0.28 (-0.69, 1.25) 
0.62e 
(-0.14, 1.38) 
0.99** 
(0.39, 1.59) 
Asian, Western 
Pacific, and Eastern 
Mediterranean 
Regions 
0.20 
(-0.21, 0.62) 
-0.15f 
(-0.69, 0.39) 
0.42* 
(0.06, 0.77) 
European Region -0.23  (-2.61, 2.14) 
-3.37g 
(-22.11, 15.37) 
-5.49** 
(-8.97, -2.01) 
American and 
Caribbean Region 
0.17 
(-1.32, 1.66) 
-3.96g 
(-11.68, 3.77) 
-0.45 
(-2.28, 1.38) 
    
 
a Includes all countries in analysis, 1986 – 2014. 
bAdjusted for population, skilled birth attendant at delivery, per capita international aid outside of the United States, 
total fertility rate, GDP, and country life expectancy. 
cAdjusted for population, skilled birth attendant at delivery, total fertility rate, and country life expectancy, 1986 – 
2014. 
d 1995 – 2014, excludes 2004 and 2006 
e 1995 – 2014, excludes 1996, 1998, 2002 – 2006  
f 1997 – 2014, excludes 2004, 2006 
g 2000 – 2001, 2007 – 2014  
h 1996 – 2001, 2005, 2007 – 2014 
 
*p < 0.05 
**p ≤ 0.005 
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Table 10. Percent Change in Maternal Mortality Ratio (cMMR) during Enactment of the 
Mexico City Policy through Multivariable Regression by High Exposure and Low Exposure 
Countries. 
Region and Exposure Level 
Unadjusted 
ΔcMMR (95% 
CI)a 
Fully Adjusted 
ΔcMMR 
(95% CI)b 
Partially Adjusted 
ΔcMMR 
(95% CI)c 
All regions and 
countries 
High -5.35 (-15.51, 4.81) 
0.66e 
(-2.32, 3.63) 
2.67** 
(1.49, 3.84) 
Low 0.25 (-0.54, 1.04) 
-1.77f 
(-4.75, 1.21) 
0.69* 
(0.06, 1.33) 
African Region 
High 0.26 (-0.68, 1.19) 
0.88g 
(-0.06, 1.81) 
0.91* 
(0.20, 1.62) 
Low 0.26 (-0.94, 1.47) 
1.37*h 
(0.30, 2.44) 
1.11** 
(0.44, 1.78) 
Asian, Western 
Pacific, and 
Eastern 
Mediterranean 
Regions 
High -0.02 (-0.85, 0.82) 
0.07i 
(-1.36, 1.50) 
0.62* 
(0.02, 1.22) 
Low 0.26* (0.08, 0.45) 
0.26j 
(-0.55, 1.06) 
0.30* 
(0.09, 0.51) 
European Region 
High -0.80 (-4.47, 2.76) 
39.36k 
(-9.97, 88.68) 
-2.11 
(-6.87, 2.64) 
Low -0.03 (-2.79, 2.74) 
-5.21l 
(-43.11, 32.69) 
-5.81* 
(-10.01, -1.60) 
American and 
Caribbean Region 
High 0.64 (-3.92, 1.67) 
-0.10m 
(-4.75, 4.55) 
-0.14 
(-1.47, 1.19) 
Low -1.03 (-5.93, 3.87) 
-8.24n 
(-37.77, 21.29) 
-2.40 
(-8.02, 3.21) 
     
SOURCES: 
a Includes all countries in analysis, 1986 – 2014. 
bAdjusted for population, skilled birth attendant at delivery, per capita international aid outside of the United States, 
total fertility rate, GDP, and country life expectancy.  All estimates represent all countries within the given 
region and exposure unless specified below. 
cAdjusted for population, skilled birth attendant at delivery, total fertility rate, and country life expectancy, 1986 – 
2014. All estimates represent all countries within the given region and exposure unless specified below. 
d See specific regions and exposures for years included in analysis 
e 1993 – 2014, excludes 1994, 2003 – 2005 
f 1996 – 2014, excludes 2004 and 2006 
g 1995 – 2014, excludes 1996, 1998, 2002 – 2006  
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h 1999 – 2014, excludes 2002 – 2006  
i 1998 – 2014, excludes 2002 – 2007 
j 1997 – 2014, excludes 2004 and 2006 
k 2000 – 2014, excludes 2001 - 2006 
l 2000 – 2014, excludes 2002 - 2006 
m 1996 – 2014, excludes 2002 - 2006 
n 1996 – 2014, excludes 2002 – 2004, 2006 
 
*p < 0.05 
**p ≤ 0.005 
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APPENDIX 1 
 
Systematic Review of the Literature Inclusion Criteriaa 
  Inclusion Criteria Exclusion Criteria 
Population Reproductive age women (15 - 49 years old)  -- 
Interventions 
Times at which there was implementation 
of the Mexico City Policy/Global Gag 
Rule (1985 - 1993, 1999 - 2000, 2001 - 
2009, 2017 - present) 
Title X (US Federal policy only), 
intra-country policies 
Comparators 
 Times at which there was not 
implementation of the Mexico City 
Policy (1993 - 1999, 2009 - 2017) 
--  
Outcomes 
Mortality, Maternal Mortality, Unsafe 
Abortion, Abortion (Induced), 
Hemorrhage, Infection, Perforation 
(Intra-organ, Uterine, or Intestine) 
Articles only focusing on 
neonatal outcomes and economic 
outcomes of the policy 
Timing 1985 - present (2018)  -- 
Settings  Developing Countries (as defined by the United Nations) Studies from developed countries 
Study Designs Case control studies, cohort studies, systematic reviews 
Non-English studies, individual 
patient case studies, opinion 
pieces (memos, editorials) 
aStudies that included both the inclusion and exclusion criteria (such as studies that included both maternal 
outcomes and neonatal outcomes) were included in the analysis. 
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APPENDIX 2 
 
Systematic Review PRISMA Diagram 
	
Flow diagram of studies included in systematic review.  Developed from www.covidence.org. 
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APPENDIX 3: 
 
Systematic Review Outcomes Table 
Article Title United States Aid Policy and Induced Abortion in Sub-Saharan Africa 
Evaluating the Mexico City Policy: How US 
Foreign Policy Affects Fertility Outcomes and 
Child Health in Ghana 
First author, 
year Bendavid, E.  2011 Jones, K.  2011 
Study 
Design Retrospective cohort study Retrospective cohort study 
Intervention 
and 
Measure 
Exposure to the Mexico City Policy. 
Reinstatement of the policy in 2001, 
measured through (1) OECD data on 
financial assistance provided by the US to 
each country, quantified via mean value of 
financial assistance per capita OR (2) 
Using USAID data. 
Period 0 (Pre-Mexico City Policy, 1981-1984), 
Period 1 (Enactment of Mexico City Policy 
1985 - 1992), Period 2 (Rescinding of Mexico 
City Policy 1993 - 2000), Period 3 (Enactment 
of Mexico City Policy, 2001 onward) 
Outcome(s) 
Odds of abortion among women of 
reproductive age. Induced abortion data 
taken from DHS (30 surveys in 20 African 
Countries, used an algorithm to distinguish 
induced abortion and spontaneous 
abortions) 
Likelihood of abortion (Woman-by-month 
panel on pregnancy conclusion: live birth, 
stillbirth, miscarriage, abortion).  Results 
further stratified by wealth, education, and 
age), probability of contraception use, number 
of pregnancies 
Sample Size  
30 DHS surveys in 20 countries, a total of 
261,116 women (1.38 million woman-
years) 
10,370 women (1.85 million observations) 
Source 
Population 
Sub-Saharan African Countries (Benin, 
Burkina Faso, Ethiopia, Ghana, Guinea, 
Kenya, Madagascar, Malawi, Mali, 
Mozambique, Niger, Nigeria, Rwanda, 
Senegal, Sierra Leone, Swaziland, Uganda, 
United Republic of Tanzania, Zambia, 
Zimbabwe) 
Women in Ghana (aged 15-49 years old) who 
participated in the 2007 Demographic and 
Health Survey 
Years 
Studied  1994 - 2008 1972 - 2007 
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Relevant 
Results 
Adjusted OR (adjusted for woman and country 
characteristics) for induced abortion was 2.55 
for high-exposure countries vs. low-exposure 
countries under the policy (95% CI 1.76 - 
3.71). Unadjusted OR 2.73 (95% CI 1.95 – 
3.82). 
• Created a woman-by-month panel and assessed 
the termination of pregnancy 
• During periods of time at which the policy was 
enacted, 2.35% more of pregnancies ended in 
abortion in rural areas (of the additional 
unwanted pregnancies resulting from the 
Mexico City Policy, 1 out of 6 were aborted) 
Strengths 
• Used two different methods to determine 
exposure to the Mexico City Policy 
• Investigated underlying mechanisms that 
could explain study findings (using data 
from UN World Contraceptive Use 
database) and adjusted analysis for age, 
marital status, urban/rural area of residence, 
education level, life expectancy, modern 
contraceptive use, and legality of abortion. 
• Also adjusted for annual per capita 
donations for family planning and 
reproductive health services from all other 
OECD countries. 
• Conducted several sensitivity analyses 
• Examined abortion rates during periods of time 
when the policy was enacted while controlling 
for age range in each time period. 
• Included a calendar-month fixed effect to 
control for seasonality of business cycles 
(during times of recessions, individuals are less 
likely to have kids) 
Compared time periods close to each other (for 
example, compared January 1990 observations 
to the 1993 policy change, as opposed to the 
1985 policy change or the 2001 policy change) 
• Used woman-fixed effects in order to compare 
each woman with herself (to control for 
unobservable characteristics about each 
woman) 
Weaknesses 
• Abortion estimates used are lower than 
other papers that use a multiplier to 
correct for underreporting 
• Only included sub-Saharan African 
countries, and thus possibly limited external 
validity 
• Changes in international funding might not 
be solely due to the Mexico City Policy but 
instead through large changes from each 
administration 
• Only examines 1 country as opposed to a 
region of countries, may have limited external 
validity 
Great differences in the policy's effect on 
abortion in woman living in rural areas as 
compared to urban areas, could again limit to 
external validity 
• Considers abortion in the context of unwanted 
and unplanned pregnancies and provides 
results in that context (calculated "unwanted 
pregnancies" from "unmet contraceptive 
need"), which could introduce an estimation 
bias 
• Excluded "poorest of the poor" women in their 
analysis 
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Potential for 
Confounding 
Bias* 
Medium – Analysis controlled for women’s 
personal characteristics (age, marital status, 
place of residence, education, country of 
residence, modern contraceptive use, legality of 
abortion).  
Medium – Controlled for unobservable differences 
in women by comparing women to themselves with 
a woman-fixed effects model.  Considered 
education, wealth, place of residence in the 
analysis. Unable to control for a change in wealth 
along a woman’s lifetime. 
Potential for 
Measurement 
Bias* 
Medium - Abortion data came from DHS, and 
although standardized, it was highly dependent 
on the women that were able to respond to the 
surveys in specified countries.  Additionally, 
had to distinguish between spontaneous and 
induced abortion via information about 
contraception prior to pregnancy, desirability of 
pregnancy, and timing of the termination of the 
pregnancy 
Medium – Assumes that unmet contraceptive need 
equates to a higher undesired pregnancy rate.  
Quality 
Assessment of 
Bias† 
Good – Conducted several sensitivity analyses 
and repeated their analysis using different 
measures of Mexico City Policy exposure. 
However, unlike the Jones article, only 
examines two periods of policy change (using 
2001 as a natural experiment). 
Moderate – Results are based in the context that an 
unmet contraceptive need equals unwanted 
pregnancy, as opposed to the Bendavid article, 
which examines unmet contraceptive need and 
actual surveys asking women about the desirability 
of the pregnancy. Limited external validity to 
countries with different abortion laws. 
*Potential for bias ranged from Low, Medium, and High 
†Quality assessment scores ranged from Good, Moderate, and Poor at the study level. 
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APPENDIX 4 
 
Variables and Transformations 
Variable Code Explanation/Source 
Enactment of 
the Mexico 
City Policy 
(mcp) 
0 = years with no policy  
(1993, 1994, 1995, 
1996, 1997, 1998, 1999, 
2009, 2010, 2011, 2012, 
2013, 2014, 2015) 
 
1 = years with policy  
(1985, 1986, 1987, 
1988, 1989, 1990, 1991, 
1992, 2000, 2001, 2002, 
2003, 2004, 2005, 2006, 
2007, 2008) 
Kaiser Family Foundation. 2018. “The Mexico City 
Policy: An Explainer.” Kaiser Family Foundation. 
https://www.kff.org/global-health-policy/fact-
sheet/mexico-city-policy-explainer/ 
 
Although in October 1999 the policy was enacted, it was 
only enacted for 3 months in that year and thus was 
considered a year “without the policy.”  The policy was 
then enacted through the year 2000 until October of that 
year and is subsequently considered an “active policy 
year.” 
Regions 
af = Africa 
sea = Southeast Asia 
wp = Western Pacific 
eur = Europe 
am = Americas 
med = Eastern 
Mediterranean 
WHO regions as divided by regional offices. 
 
World Health Organization. 2018. “WHO Regional 
Offices.” World Health Organization. 
http://www.who.int/about/regions/en/ 
Maternal 
Morality 
Ratio (mmr) 
mmr 
The ratio of the number of maternal deaths during a given 
time period per 100,000 live births during the same time-
period, where a maternal death is defined as a female 
death from any cause related to or aggravated by 
pregnancy or its management (excluding accidental or 
incidental causes) during pregnancy and childbirth or 
within 42 days of termination of pregnancy, irrespective 
of the duration and site of the pregnancy. From: WHO, 
UNICEF, UNFPA, World Bank Group, and the United 
Nations Population Division.  2015. “Trends in maternal 
morality: 1990-2015.” WHO Sexual and Reproductive 
Health. WHO /RHR/15.23. 
http://www.who.int/reproductivehealth/ 
publications/monitoring/maternal-mortality-2015/en/ 
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Percent 
Change in 
Maternal 
Mortality 
cMMR 
Calculated by subtracting the former year from the latter 
year, dividing by the former, and multiplying this result by 
100.  Example: Subtracting MMR of 1990 from 1989, 
dividing by the MMR of 1989, and multiplying by 100. 
General 
Fertility Rate 
(gfr) 
gfr 
From: The United Nations World Population Division, 
Total Fertility Rate. Defined as the average number of live 
births a hypothetical cohort of women would have at the 
end of their reproductive period if they were subject 
during their whole lives to the fertility rates of a given 
period and if they were not subject to mortality. Expressed 
as live births per woman. 
https://esa.un.org/unpd/wpp/Download/Standard/Fertility/ 
GDP (gdp) gdp 
From: The World Bank Databank, GDP per capita, PPP 
(constant 2011 $). 
http://databank.worldbank.org/data/reports.aspx?source=w
orld-development-indicators#  
Population 
(pop) pop 
From: US Census Bureau International Database. Midyear 
Population and Density, 1985-2015. 
https://www.census.gov/data-
tools/demo/idb/informationGateway.php 
Life 
expectancy 
(exp) 
exp 
From: The World Bank Databank. Life Expectancy at 
birth, total (years) 1985-2015. 
https://data.worldbank.org/indicator/SP.DYN.LE00.IN. 
(1) United Nations Population Division. World Population 
Prospects: 2017 Revision, or derived from male and 
female life expectancy at birth from sources such as: (2) 
Census reports and other statistical publications from 
national statistical offices, (3) Eurostat: Demographic 
Statistics, (4) United Nations Statistical Division. 
Population and Vital Statistics Report ( various years ), (5) 
U.S. Census Bureau: International Database, and (6) 
Secretariat of the Pacific Community: Statistics and 
Demography Programme. 
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Financial 
assistance 
from the US 
(usaid) 
Low = Below the median 
financial aid distributed 
from the US 
High = Above the median 
financial aid distributed 
from the US 
Added donations from the United States in Family 
Planning  (Sector 13030) and Reproductive Health (Sector 
13020).  Flow: Official Development Assistance. All 
Channels, current prices, all types of aid.  From: OECD 
Credit Report System. 
https://stats.oecd.org/Index.aspx?DataSetCode=CRS1 
Financial 
assistance for 
other 
countries 
(worldaid) 
worldaid 
Subtracted United States donations (above) from total  
world donations in Family Planning  (Sector 13030) and 
Reproductive Health (Sector 13020).  Flow: Official 
Development Assistance. All Channels, current prices, all 
types of aid. From: OECD Credit Report System. 
https://stats.oecd.org/Index.aspx?DataSetCode=CRS1 
   
 
 
